Results 31 to 40 of about 78,509 (213)
Snakebite envenoming is an important public health issue with devastating consequences and annual mortality rates that range between 81,000 and 138,000.
Mátyás A. Bittenbinder +8 more
doaj +1 more source
The cytotoxicity caused by snake venoms is a serious medical problem that greatly contributes to the morbidity observed in snakebite patients. The cytotoxic components found in snake venoms belong to a variety of toxin classes and may cause cytotoxic ...
Eric Wachtel +8 more
doaj +1 more source
What Are the Neurotoxins in Hemotoxic Snake Venoms? [PDF]
Snake venoms as tools for hunting are primarily aimed at the most vital systems of the prey, especially the nervous and circulatory systems. In general, snakes of the Elapidae family produce neurotoxic venoms comprising of toxins targeting the nervous ...
Osipov A, Utkin Y.
europepmc +2 more sources
Snake venom ophthalmia is caused by venoms of spitting elapid and other snakes. The cobra is one of the most venomous snakes of genus Naja. There are more than 20 species of cobra like the King cobra of South Africa, Thailand, Burma, China, India, Malaysia, Philippines; the spitting cobra of Africa and parts of South East Asia; the Indian cobra found ...
Vijay Kumar, Sharma, V K, Baranwal
openaire +2 more sources
Comparative electrophoretic studies were conducted on the venom of the rinkals (Hemachatus haemachatus). Egyptian cobra Naja haje haje) and puffadder (Bills arietans). Considerable differences in electrophoretic characteristics were found between fresh venom and commercial venom samples from the same species of snake.
Willemse, GT, Hattingh, J.
openaire +2 more sources
At least 2000 persons are bitten by venomous snakes in the United States each year. This article reviews the diagnosis and management of bites from venomous snakes encountered in North America, but the same principles apply to management of snakebites elsewhere in the world.
Barry S, Gold +2 more
openaire +5 more sources
Polyvalent Snake Antivenoms: Production Strategy and Their Therapeutic Benefits
Snake envenomation remains an important yet neglected medical problem in many countries, with around five million people affected, and over a hundred thousand deaths annually. Plasma-derived antivenoms are the main therapeutic agent available. Monovalent
Kavi Ratanabanangkoon
doaj +1 more source
Suramin inhibits the early effects of PLA(2) neurotoxins at mouse neuromuscular junctions: a twitch tension study [PDF]
Several phospholipase A(2) (PLA(2)) neurotoxins from snake venoms can affect acetylcholine release at the neuromuscular junction. In isolated nerve-muscle preparations three distinct phases have been described for this phenomenon: An initial transient ...
Fathi, Behrooz +2 more
core +3 more sources
Snake venoms have been fervently studied for decades for two reasons: 1) high death rate due to snake bites; 2) numerous components of snake venoms prove useful in medicine and treatment of diverse pathologies. Snake venom phospholipases A2 are among the
L. V. Galebskaya +3 more
doaj +1 more source
Human envenoming by Australian brown snakes (Pseudonaja spp.) may result in potentially life-threatening hypotension and subsequent cardiovascular collapse.
Nhi Thuc Vuong +2 more
doaj +1 more source

